Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SIGA TechnologiesSIGA +1.86%60 Cash Ratio is 14.99 as of Jun. 2026, which is 218% above its 10-year median of 4.71. GuruFocus rates SIGA with a GF Score™ of 60/100 and a GF Value™ of $2.55 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 965 Drug Manufacturers companies, SIGA Technologies ranks better than 97.93% on this metric.
SIGA Technologies has a Cash Ratio of 14.99. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for SIGA Technologies's Cash Ratio or its related term are showing as below:
SIGA'
s Cash Ratio Range Over the Past 10 Years
Min: 0.03 Med: 4.71 Max: 21.17
Current: 14.99
During the past 13 years, SIGA Technologies's highest Cash Ratio was 21.17. The lowest was 0.03. And the median was 4.71.
SIGA's Cash Ratio is ranked better than 97.93% of 965
companies
in the Drug Manufacturers industry
Industry Median: 0.58
vs SIGA: 14.99
SIGA Technologies (NAS:SIGA) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
SIGA Technologies Cash Ratio Related Terms
SIGA Technologies Cash Ratio Historical Data
* Premium members only.
The historical data trend for SIGA Technologies's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SIGA Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SIGA Technologies Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SIGA Technologies's Cash Ratio distribution charts can be found below:
* The bar in red indicates where SIGA Technologies's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SIGA Technologies (SIGA) has a Cash Ratio of 14.99 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on SIGA Technologies and its competitors. This is 218% above median its historical median of 4.71. Over the past decade, SIGA Technologies' Cash Ratio has ranged from 0.03 to 21.17. According to the industry distribution chart, SIGA Technologies ranks #20 out of 965 companies in the Drug Manufacturers industry, placing it in the top 2.1%.
Is SIGA Technologies' Cash Ratio too high?
SIGA Technologies' current Cash Ratio of 14.99 is 218% above median its 10-year median of 4.71. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 21.17. The Drug Manufacturers industry median Cash Ratio is 0.58. SIGA Technologies' value of 14.99 is 2484.5% above this industry median. Based on the distribution chart, SIGA Technologies ranks #20 out of 965 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, SIGA Technologies has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SIGA Technologies' Cash Ratio compare to ORGO and DERM?
According to the Drug Manufacturers industry distribution chart, SIGA Technologies ranks #20 out of 965 companies for Cash Ratio. This places SIGA Technologies in the top 2% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.58. SIGA Technologies' value of 14.99 is 2484.5% above this benchmark. Historically, SIGA Technologies' own Cash Ratio has ranged from 0.03 to 21.17 over the past decade. While the company's 10-year median is 4.71 vs. the industry median of 0.58, SIGA Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.58, based on 965 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SIGA Technologies's current Cash Ratio of 14.99 is 2484.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on SIGA Technologies and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SIGA Technologies's current Cash Ratio is 14.99, which is 218% above median its own 10-year median of 4.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SIGA Technologies stock overvalued right now?
Based on GuruFocus' analysis, SIGA Technologies (SIGA) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.55, compared to a current price of $3.29 — trading 29% above its estimated fair value. The current Cash Ratio is 14.99, which is 218% above median its 10-year median of 4.71 and 2484.5% above the Drug Manufacturers industry median of 0.58. SIGA Technologies' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For SIGA Technologies (SIGA), the current Cash Ratio is 14.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SIGA Technologies (SIGA) Overvalued in 2026?
Based on GuruFocus' analysis, SIGA Technologies stock appears to be overvalued.
The current stock price of $3.29 is trading 29% above its estimated GF Value™ of $2.55.
GuruFocus considers SIGA Technologies to be Modestly Overvalued.
Key valuation signals for SIGA:
Cash Ratio: 14.99 (218% above median its 10-year median of 4.71)
GF Value™: $2.55 vs. price of $3.29 (29% above fair value)
Industry Position: 2484.5% above the Drug Manufacturers median (#20 of 965)
No single metric tells the full story. See the SIGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
60GF Score
Get the complete analysis for SIGA
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SIGA has been successfully added to your 
